By Matthew Bultman ( May 5, 2017, 6:13 PM EDT) -- The Federal Circuit ruled Friday that Breckenridge Pharmaceutical Inc.'s planned generic version of the laxative drug Suprep infringes a patent owned by Braintree Laboratories Inc., reversing a New York federal judge's 2016 ruling....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.